CLINICAL JOURNEY ANALYTICS AND MARKET SIZING
Quantify the clinical journey81qd uses over a billion data points of RWD to create market-sizing metrics of current clinical practice. This allows us to analyze clinical journeys that encompass the great majority of patients within any disease state, along with more than 95% of all clinicians.We avoid the pitfalls of the traditional primary market approach by going into great depth on the experience of patients along with the breadth of patient/physician interaction. We then include important non-core specialties to delineate multiple journeys in any disease state. |
Leverage the analysis to build a broader understanding of patients and treatment plans81qd uses real-world claims data to capture how patients flow through HCP specialties and treatments from diagnosis through management. This assessment allows our clients to build a foundational understanding of the patient journey based on factual claims analysis that captures all patient interactions. |
PRODUCT ADOPTION ANALYTICS
Drive product adoption
Orion analytics go well beyond the historical approaches of assessing likely adoption based on broad segmentation and extrapolation based on research using analog products. Orion leverages machine learning to assess thousands of patient and HCP features to identify and weigh their roles in driving adoption.These insights provide our clients with tools to optimize HCP targeting and engagement to drive product adoption.
Identify HCPs managing patients likely to adopt a therapy
To predict the practices with patients likely to adopt a specific product, 81qd leverages claims data and machine learning to assess thousands of patient and HCP features to identify and weigh their role in driving adoption. Orion identifies patients that are likely adopters of a specific product and the HCPs who are currently managing these patients.Clients can leverage Orion analytics within marketing initiatives/campaigns to engage directly and across multiple digital channels.
THERAPY ADHERENCE ANALYTICS
Maximize therapy adherence
Nonadherence to a medication is a complex healthcare problem, driven by a myriad of both patient- and HCP-related factors, such as:
Patient-driven factors:
HCP-driven factors:
81qd offers clients the ability to be proactive in efforts to address nonadherence by leveraging machine learning to identify HCP practices with the highest probability of patients likely to be nonadherent to therapy and provide targeted interventions to improve adherence.
| • | Demographics |
| • | Ability to follow a medication regimen |
| • | Willingness to pay for a medication regimen |
HCP-driven factors:
| • | Prescribing patterns |
| • | Practice attributes |
| • | Historical adherence patterns |
81qd offers clients the ability to be proactive in efforts to address nonadherence by leveraging machine learning to identify HCP practices with the highest probability of patients likely to be nonadherent to therapy and provide targeted interventions to improve adherence.
Identify HCPs managing patients likely to be nonadherent to therapy
To identify the practices likely to have nonadherent patients, machine learning structures and finds interrelations between patient and HCP features, then assesses which features are predictive of nonadherence for a specific product and disease. Our clients can then leverage these findings to proactively engage and educate clinicians and patients across channels.
These applications span our clients' core business needs...
| • | Effectively target disease management interventions |
| • | Optimize resource allocation |
| • | Improve financial support program efficiency and effectiveness |
Request a demo